Tolmar

ELIGARD

  1. Home
  2.  / 
  3. J Code
  4.  / ELIGARD – J9217

Manufacturer:

Tolmar

Name:

ELIGARD

HCPCS Code Descriptor:

Leuprolide acetate (for depot suspension), 7.5 mg

Category:

J Code

HCPCS:

J9217

NDC(s):

00074-3346-03, 00074-3473-03, 00074-3642-03, 00074-3683-03, 62935-0453-45, 62935-0753-75, 62935-0303-30, 62935-0223-05, 00074-2440-03, 00074-2108-03

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intramuscular

About:

ELIGARD is an Oncology drug manufactured by Tolmar and administered via the Intramuscular route of administration. The J Code: J9217 is aligned to the drug ELIGARD.

Eligard is used to minimize the symptoms of certain cancers through hormone therapy. By initially causing the overproduction of certain hormones, Eligard causes the body to stop producing these select hormones all together. Eligard is a branded drug manufactured by Tolmar Pharmaceuticals. Patient assistance programs for Eligard can be found through Tolmar Pharmaceuticals.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/91

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Leuprolide acetate suspnsion

Billing and Coding Guide:

Not Found

Patient Assistance:

https://eligardhcp.com/coverage-reimbursement

ELIGARD - J9217